García GRJ, Olmos EUJ, Corrales AI

Language: Spanish
References: 25
Page: 1-8
PDF size: 549.54 Kb.

ABSTRACT

Objective: To describe the necessary approaches for diagnosis of children and adolescents with acute encephalopathy, it´s main clinical manifestations and laboratory tests of more frequent disorders that are reason of attention in emergency services.
Development: One algorithm about the general actuation for diagnosis in children and adolescents with acute encephalopathy is delineated. Initially, is established the concept of acute encephalopathy, and are considered main clinical manifestations: disorders of consciousness, mental function, and occurrence of epileptic seizures and other neurological manifestations of focalization or dysfunction. In second place, in patient with criteria of acute encephalopathy, is very important to definite if clinical manifestations are consistent with encephalitis or not. Here is presented an option for diagnosis of patient with encephalitis, emphasizing on the laboratory tests and neuroimaging for diagnosis and cause determination. After that, are mentioned the main options in diagnosis of acute encephalopathy that do not fulfill the criterions, neither of infectious encephalitis or immune–mediated neurologic diseases, and are mentioned fundamental elements that make to suspect them.
Conclusions: The proposed organization for the diagnosis of acute encephalopathy and disorders that are motive of it, it is a contribution for to get betters the attention on this serious situation that needs an effective and fast conduct. This approach can be the key for diagnosis in child neurology practice and appropriate conduct determination.

REFERENCES

1. Lewis P, Glaser C. Encephalitis. Pediatr Rev. 2005;26:353–63.

2. Winfield T, McHugh C, Vas A, Richardson A, Wilkinson E, Bonington A, Varma A. Autoimmune encephalitis: a case series and comprehensive review of the literature. Q J Med. 2011;104:921–31.

3. Irani SR. Autoimmune encephalitis – New awareness, challenging questions. Discovery medicine. 2011;11(60):449–58.

4. Ropper AH, Brown RH. Principios de Neurología, de Adams y Víctor. 8 ed. México, D. F.: McGraw–Hill Interamericana Editores, S.A. de C. V. 2007. p. 302–4.

5. Kirkham FJ. Non–traumatic coma in children. Arch Dis Child. 2001;85:303–12.

6. Beghi E, Carpio A, Forsgren L, Hesdorffer DC, Malmgren K, Sander JW, et al. Recommendation for a definition of acute symptomatic seizure. Epilepsia. 2010;51(4):671–5.

7. Nabbout R, Vezzani A, Dulac O, Chiron C. Acute encephalopathy with inflammation–mediated status epilepticus. Lancet Neurol. 2011;10(1):99–108.

8. Semmler A , Hermann S, Mormann F, Weberpals M, Paxian SA, Okulla T, et al. Sepsis causes neuroinflammation and concomitant decrease of cerebral metabolism. J Neuroinflammation. 2008;5(38):1–10.

9. Finelli PF, Uphoff DF. Magnetic resonance imaging abnormalities with septic encephalopathy. J Neurol Neurosurg Psychiatry. 2004;75:1189–91.

10. Bartynski WS, Boardman JF, Zeigler ZR, Shadduck RK, Lister J. Posterior Reversible Encephalopathy Syndrome in Infection, Sepsis, and Shock. AJNR Am J Neuroradiol. 2006;27(10):2179–90.

11. Romem A, Galante O, Shelef I, Almog Y. Posterior reversible encephalopathy syndrome complicating septic shock. Isr Med Assoc J. 2011;13(12):776–8.

12. Ambrose HE, Granerod J, Clewley JP, Davies NWS, Keir G, Cunningham R, et al. Diagnostic Strategy Used To Establish Etiologies of Encephalitis in a Prospective Cohort of Patients in England. J Clin Microbiol. 2011;49(10):3576–83.

13. Huy NT, Thao NTH, Diep DTN, Kikuchi M, Zamora J, Hirayama K. Cerebrospinal fluid lactate concentration to distinguish bacterial from aseptic meningitis: a systemic review and meta–analysis. Critical Care. 2010,14:1–15.

14. Kim K. New diagnostic and Therapeutic options in Bacterial meningitis in infants and children. Minerva Pediátrica. 2009;61(5):531–48.

15. García–Moncó JC. Encefalitis agudas. Neurología. 2010;25(Supl 1):11–7.

16. Jiménez–Caballero PE, Montes–Gonzalo MC, Velázquez–Pérez JM. Síndrome de Reye. Descripción de un caso con especial interés en sus crisis epilépticas. Rev Neurol. 2008;47(11):571–4.

17. National Institutes of Health. Diagnosis and treatment of Reye’s syndrome. JAMA. 1981;246:2441–4.

18. Chaves–Carballo E. Detection of inherited neurometabolic disorders. A practical clinical approach. Pediatr Clin North Am. 1992;39(4):801–19.

19. Raghuveer TS, Garg U, Graf W. Inborn errors of metabolism in infancy and early childhood: an update. Am Fam Physician. 2006;73:1981–90.

20. Cleary MA, Green A. Developmental delay: when to suspect and how to investigate for an inborn error of metabolism. Arch Dis Child. 2005;90;1128–32.

21. Inaba H, Khan RB, Laningham FH, Crews KR, Pui CH, Daw NC. Clinical and radiological characteristics of methotrexate–induced acute encephalopathy in pediatric patients with cancer. Ann Oncol. 2008;19(1):178–84.

22. Bjornsson E. Hepatotoxicity associated with antiepileptic drugs. Acta Neurol Scand. 2008:118:281–90.

23. Soomro A, Al Bahri R, Alhassan N, Hejaili FF, Al Sayyari AA. Posterior reversible encephalopathy syndrome with tactile hallucinations secondary to dialysis disequilibrium syndrome. Saudi J Kidney Dis Transpl. 2014;25(3):625–9.

24. Hoffman WH, Siedlak SL, Wang Y, Castellani RJ, Smith MA. Oxidative damage is present in the fatal brain edema of diabetic ketoacidosis. Brain Res. 2011;1369:194–202.

25. Ferracci F, Bertiato G, Moretto G. Hashimoto's encephalopathy: epidemiologic data and pathogenetic considerations. J Neurol Sci. 2004;15(2):165–8.